Trial Profile
Plerixafor in Chinese Patients with Non-Hodgkin Lymphoma, a Pharmacokinetics and Pharmacodynamic study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors Sanofi
- 27 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.